PMDI · Psychemedics Corp
Market Cap
$15.21M
Shares
6.11M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Brian Hullinger | CEO, & President | $762,558 |
| Raymond C. Kubacki | Former Chairman, CEO, & President | $619,906 |
| Charles M. Doucot | Former Executive Vice President | $284,438 |
| Michael I. Schaffer | Former Vice President, Laboratory Operations | $274,433 |
| Shannon Shoemaker | Chief Revenue Officer | $261,408 |
| Daniella Mehalik | Vice President - Finance | $11,939 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Raymond C. Kubacki | Former Chairman, CEO, & President | $600,338 |
| Charles M. Doucot | Former Executive Vice President | $369,506 |
| Michael I. Schaffer | Former Vice President, Laboratory Operations | $293,706 |
| Brian Hullinger | CEO, & President | — |
| Daniella Mehalik | Vice President - Finance | — |
| Shannon Shoemaker | Chief Revenue Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Raymond C. Kubacki | Chairman, CEO, & President | $623,852 |
| Charles M. Doucot | Executive Vice President | $341,350 |
| Michael I. Schaffer | Vice President Labortory Operations | $277,499 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Raymond C. Kubacki | Chairman, CEO, & President | $685,201 |
| Charles M. Doucot | Executive Vice President | $397,693 |
| Michael I. Schaffer | Vice President Labortory Operations | $313,454 |